The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUNG.L Regulatory News (UNG)

  • There is currently no data for UNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Universe Group plc

2 Dec 2021 11:30

RNS Number : 3821U
Universe Group PLC
02 December 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Universe Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Universe Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

02-12-2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

N/A

N/A

N/A

N/A

(2) Cash-settled derivatives:

 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

 

TOTAL:

N/A

N/A

N/A

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(1) Interests of directors (together with their close relatives and related trusts) of Universe Group plc in the ordinary shares of £0.01 each

 

Director

Number of ordinary shares

% of issued ordinary shares (2 d.p.)

Andrew Blazye

20,342,785

7.79%

Neil Radley

1,999,790

0.77%

Malcolm Coster

9,215,754*

3.53%

Ivan Brooks

520,736**

0.20%

Adrian Wilding

200,000

0.08%

 

Director

Number of options

Date of award

Plan

Exercise price

Date from which exercisable

Expiry

Neil Radley

12,700,000

20 July 2021

Unapproved Plan

5.4p

20 July 2024

20 July 2026

Malcolm Coster

100,000

28 October 2014

Unapproved Plan

5.5p

28 October 2017

28 October 2024

Adrian Wilding

5,000,000

20 July 2021

Unapproved Plan

5.4p

20 July 2024

20 July 2026

 

*Includes 6,371,643 shares held in the name of Teresa Coster, who is Malcolm Coster's daughter in law.

 

**Includes 78,236 shares held in the name of Thomas Brooks and 42,500 shares held in the name of Alexander Brooks, who are Ivan Brooks' sons.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

2 December 2021

Contact name:

Adrian Wilding

Telephone number:

+44 2380 689 510

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFLFLLFSLFIIL
Date   Source Headline
12th Mar 20217:00 amRNSDirectorate Change
26th Feb 20217:00 amRNSCEO Transition Plan and Board Changes
21st Dec 20207:00 amRNSTrading Update
13th Oct 20207:00 amRNSAppointment of interim CFO
29th Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSBoard Change
22nd Jul 202010:50 amRNSExercise of Options
30th Jun 202012:33 pmRNSResult of AGM
8th Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Dealing
21st May 20207:00 amRNSFinal Results for the Year Ended 31 December 2019
5th May 202011:05 amRNSSecond Price Monitoring Extn
5th May 202011:00 amRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSTrading and COVID-19 Update
25th Sep 20197:00 amRNSInterim Results
24th Sep 20193:45 pmRNSExercise of Options and Total Voting Rights
21st Aug 20197:00 amRNSDirector/PDMR Shareholding
27th Jun 201911:45 amRNSExercise of Options and TVR
25th Jun 201912:15 pmRNSResult of AGM
25th Jun 20197:00 amRNSAGM Statement
1st May 20193:36 pmRNSHolding(s) in Company
30th Apr 20192:34 pmRNSHolding(s) in Company
23rd Apr 20197:00 amRNSDirectorate Change
17th Apr 20197:00 amRNSFinal Results
3rd Apr 20191:32 pmRNSAcquisition of Camden Technology
11th Mar 20193:29 pmRNSHolding(s) in Company
8th Mar 201912:32 pmRNSHolding(s) in Company
9th Jan 20197:00 amRNSNew Payment Service Launch With Euro Garages
15th Nov 201812:34 pmRNSHolding(s) in Company
25th Oct 20187:00 amRNSLaunch of Scan and Go App
9th Oct 20187:00 amRNSMOBILE PAYMENT PARTNERSHIP WITH P97 NETWORKS INC
19th Sep 20187:00 amRNSInterim Results
26th Jun 201812:30 pmRNSResult of AGM
26th Jun 20187:00 amRNSAGM Statement
15th Jun 20188:26 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSFinal Results
10th Apr 20187:00 amRNSUpdate Re Exercise of Options
5th Apr 201812:16 pmRNSExercise of Options and Total Voting Rights
12th Mar 20187:00 amRNSNext Generation EPOS Installed in 70th Rontec Site
7th Mar 20182:49 pmRNSHolding(s) in Company
7th Mar 20187:00 amRNSAgreement Signed With NetPay Merchant Services Ltd
27th Nov 20177:00 amRNSBoard Change
27th Nov 20177:00 amRNSTrading Update
7th Nov 20172:19 pmRNSHolding(s) in Company
20th Oct 20176:02 pmRNSHolding(s) in Company
11th Oct 20177:00 amRNSUniverse Commences Gempay 3 Roll Out
6th Oct 20173:49 pmRNSHolding(s) in Company
5th Oct 201712:03 pmRNSHolding(s) in Company
2nd Oct 20175:00 pmRNSHolding(s) in Company
26th Sep 20177:01 amRNSBOARD CHANGES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.